Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14% 
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake 
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook 
Meta Agrees to $18 Billion Settlement, Tightens Teen Social Media Rules 
The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question 
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’ 
OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing 
Google Changes EU Spam Policy Amid Antitrust Scrutiny 
Street Poller Media and The Boom of the Street Interview Ad Industry 
Jefferies Names AMEC Top China Semiconductor Equipment Pick 
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation 
Mercer International Stock Surges 45% on C$20 Million Canada Funding 
Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns 
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns 
Honda, Nissan Eye Shared Vehicle Software Platform by 2029 
PayPal Shares Sink as $50 Billion Takeover Bid Collapses 
Amazon Secures 200 MW Wind Power Deals in Sweden 
Add as a preferred source on Google
PLEASANTON, Calif., April 11, 2018 -- Natus Medical Incorporated (NASDAQ:BABY) today announced that the Company will release its 2018 first quarter financial results before the market opens on Wednesday, April 25th. Natus management will host an investment-community conference call the same day beginning at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time) to discuss those results and to answer questions.
Individuals interested in listening to the conference call may do so by dialing 1-844-634-1441 for domestic callers, or 1-508-637-5658 for international callers, and entering reservation code 3261649. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 1-855-859-2056 for domestic callers, or 1-404-537-3406 for international callers, and entering reservation code 3261649.
The conference call also will be available real-time via the Internet at http://investor.natus.com and a recording of the call will be available on the Company's Web site for 90 days following the completion of the call.
About Natus Medical Incorporated
Natus is a leading provider of healthcare products and services used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, neurosurgery, epilepsy, sleep disorders, and balance and mobility disorders.
Additional information about Natus Medical can be found at www.natus.com.
COMPANY CONTACT:
Natus Medical Incorporated
Jonathan A. Kennedy
Executive Vice President and Chief Financial Officer
(925) 223-6700
[email protected]
